Some SGLT2 inhibitors increase risk of loss of bone mineral density and fractureRare side effect reported with canagliflozin, and with dapagliflozin in patients with moderate renal impairment. $1 million commitment to improve wellness around the globe through diabetes prevention and management A cost-cutting success story: Limiting test-strip reimbursement does not harm diabetes patients Ontario decision saved millions without worsening rates of dysglycemia, study finds Sleep-deprived preschoolers likely to eat too much Cholesterol-lowering meds to increase diabetes risk? Yogurt may play key role in diabetes prevention Canadian researcher Shirin Panahi sheds light on this potential superfood Diabetes international press review – October 26, 2016 Medtronic announces Health Canada licence of the Minimed™ 630G system New user-friendly insulan pump design and Smartguard™ technology Type 2 diabetes management: A new era has emerged How recent cardiovascular safety trials will change your approach to antihyperglycemic therapy Clinical Q&A: Enhancing type 1 diabetes care Doctor-patient group aims to improve treatment of the condition First Previous 28 29 30 31 32 Next Last
